Distil ← Back to home
Medication · antimuscarinic urinary

Supplements and Oxybutynin.

Every documented pair, every citation. Below: 1 documented pair grouped by mechanism.

Oxybutynin, sold under the brand names Ditropan, Lyrinel XL, Kentera, is an antimuscarinic agent for urinary urgency or overactive bladder.

Oxybutynin is an antimuscarinic agent for urinary urgency or overactive bladder. The class blocks muscarinic acetylcholine receptors in the detrusor muscle, reducing involuntary contraction. UK prescribing includes solifenacin, tolterodine, oxybutynin, and mirabegron (technically a beta-3 agonist but in the same prescribing space). The supplement surface includes additive anticholinergic burden, which matters most in older patients given the cognitive decline signal that has emerged in long anticholinergic exposure data. Supplements with anticholinergic potential at high doses (some choline pathway compounds in reverse, certain antiemetic herbals) warrant care. Dry mouth. Constipation. Urinary retention. All three scale with dose. The NICE NG123 guideline pushes for review of indication and dose every six to twelve months, given the cognitive burden picture.

Below are the 1 documented pair we have explicitly assessed against Oxybutynin in the Distil database: 1 amber. The pairs cluster around 1 mechanism: Cholinergic vs anticholinergic (opposing). Every call is cited to either a clinical reference (PMID) or the British National Formulary. Anything not on this list is either still to be assessed or beyond our database scope. The checker beneath surfaces assessments by supplement, and the missing-item form at the bottom of the page routes any uncatalogued supplement into our next curation pass.

Documented interactions

Last reviewed 15 June 2026. Each interaction below is assessed against PubMed-indexed evidence.

Cholinergic vs anticholinergic (opposing)

Amber Does Huperzine A interact with ?

Huperzine A raises acetylcholine while oxybutynin blocks it, so each can work against the other. Huperzine A may make oxybutynin less effective for bladder symptoms, and oxybutynin may blunt any benefit from huperzine A. It is not dangerous, but the two are pulling in opposite directions, so it is worth a word with your prescriber.

Evidence: Based on an established mechanism, with no direct study of this exact combination yet.

PMID 29350336 · PMID 18425924 · BNF: Oxybutynin

Reviewer-flagged: awaiting clinical-reviewer sign-off.

What this list does not say. Pairs not flagged here are not implicitly safe. They are either not yet in our database, or fall outside our inclusion scope (food-supplement interactions only; for drug-drug interactions, the BNF is authoritative). Use the checker below to surface any supplement, and submit a missing item if you take something we have not catalogued.

Loading database stats…

No affiliates. No commission. We earn nothing on what you buy.

For adults over 18. This tool gives evidence-graded information, not medical advice. Always discuss changes with your GP or pharmacist, especially if you take any medication, are pregnant, breastfeeding, or have a serious health condition.
Add every supplement you take. Type a name and click each match to add it, as many as you like.
Add all your medications, brand or generic. Type and click each match to add it.
Anything we should know? (optional)
Pick any that apply. We adjust the findings where context changes the answer.
Add all the supplements and medications you take, then check them together in one go.
Not sure where to start? Try one:
How we decide

How we grade severity, choose what's in scope, and what we exclude.

Every call on this page is reasoned. We publish the full rubric for severity tiers, the medication inclusion logic, the evidence grades we accept, and what we deliberately leave out. About three thousand words. Worth reading once if you use this tool more than occasionally.

Read the full methodology
Your whole stack

Want this checked across everything you take?

This page checks the pairs you enter. The personalised Distil report goes further:

  • the same graded, cited interaction check across your whole stack, not just the pairs you thought to type in
  • where your current routine may be leaving you short of your goals
  • the evidence-graded compounds worth adding, and the ones worth dropping

It's a paid report: £79, or £49 founder pricing while we earn our first reviews. The interactions check is one section of it, and you can read a real one in full before you decide.

See a real sample report
Distil's interactions database is reviewed and updated every quarter. We grade evidence transparently and publish our methodology, including every database change, at /about/methodology. This tool is information, not a substitute for clinical judgement. If you take medication and supplements together, your GP or pharmacist can review your full regimen against your medical history. If you want a full personalised stack reasoned against this same database, the Distil report is the next step up.